BMY

🇺🇸 US

Bristol-Myers Squibb Company

Healthcare

56

Price

61.48 USD

Market cap

$125.59B

Current yield

4.1%

Avg yield

3.9%

P/E

13.5

Net debt / EBITDA

1.80

5Y EPS growth

3.7%

1Y return

41.2%

Score breakdown

Current yield

Current dividend yield must be at least 8% to match the Börsdata screen.

4.1%

≥ 8%

Avg yield

Long-term average yield (5-year proxy) must also be at least 8%.

3.9%

≥ 8%

Net debt / EBITDA

Net debt below 2x EBITDA keeps leverage from eating the dividend.

1.80

< 2

Return metric

ROE ≥ 15% signals the business earns well on equity. Falls back to ROI, ROIC or ROA when ROE is unavailable.

46.6% (ROE)

≥ 15%

P/E ratio

P/E below 15 aims to avoid overpaying for the income stream.

13.5

< 15

5Y EPS growth

5-year EPS growth ≥ 10% suggests the dividend has some underlying growth support.

3.7%

≥ 10%

1Y performance

1-year performance ≥ 0% filters out stocks in severe near-term downtrends.

41.2%

≥ 0%

Total score56
Dividend history

Current yield (last 12 months paid): 4.1%. Bars show each calendar year; the latest bar is year-to-date.

20172.5%(1.560 USD)
20183.1%(1.600 USD)
20192.6%(1.640 USD)
20203.7%(2.290 USD)
20212.4%(1.470 USD)
20223.0%(2.160 USD)
20234.4%(2.280 USD)
20244.2%(2.400 USD)
20254.6%(2.480 USD)
2026 YTD4.1%(2.520 USD)

Return metric shown: 46.6% (ROE). Yahoo does not always provide ROE; ROI, ROIC or ROA is used as a fallback.